Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00027885
Status:
COMPLETED
Last Update Posted:
2013-06-17
First Post:
2001-12-07
Brief Title:
Phase II Bevacizumab Tax In Advanced Breast Cancer
Sponsor:
Case Comprehensive Cancer Center
Organization:
Case Comprehensive Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-11
Start Date Type:
None
Primary Completion Date:
2005-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-08
Completion Date Type:
ACTUAL
First Submit Date:
2001-12-07
First Submit QC Date:
January 26 2003
Study First Post Date:
2003-01-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-06-14
Last Update Post Date:
2013-06-17
Last Update Post Date Type:
ESTIMATED